Class II · Moderate risk
Levetiracetam
Failed Dissolution Specifications: 6 month time point.
FDA Drug Recalls
1,711 recalls, newest first
Class I · High risk
0.9% Sodium Chloride Injection
Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
Class I · High risk
Avastin (Bevacizumab)
Non-Sterility: Product tested positive for bacterial contamination.
Class I · High risk
Avastin (Bevacizumab)
Non-Sterility: Product tested positive for bacterial contamination.
Class I · High risk
fentaNYL Citrate
Subpotent Drug
Class I · High risk
fentaNYL Citrate
Subpotent Drug
Class II · Moderate risk
Daytrana (methylphenidate transdermal system)
Defective Delivery System: One lot exceeded the mechanical peel specification
Class III · Low risk
5-methyltetrahydrofolate Calcium
Subpotent Drug
Class I · High risk
Practi-0.9% Sodium Chloride
Non-sterility: Product is made in a non-sterile facility and is not intended for use in humans or animals.
Class II · Moderate risk
Benzonatate Capsules
Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Class II · Moderate risk
Glycopyrrolate injection
Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".